Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toos Daemen

Showing results (11-20 of 82) with videos related to

Pageof 9
Sort By:
Vaccine|July 4, 2024
An in vitro CD8 T-cell priming assay enables epitope selection for hepatitis C virus vaccinesGeorgia Koutsoumpli, Neringa Stasiukonyte, Baukje Nynke Hoogeboom, et al.
Oncoimmunology|May 8, 2015
Myeloid derived suppressor cells-An overview of combat strategies to increase immunotherapy efficacyOana Draghiciu, Joyce Lubbers, Hans W Nijman, et al.
Scientific Reports|November 21, 2024
Effects of virus-induced immunogenic cues on oncolytic virotherapyDarshak K Bhatt, Thijs Janzen, Toos Daemen, et al.
Cancer Immunology, Immunotherapy : CII|November 23, 2018
An alphavirus-based therapeutic cancer vaccine: from design to clinical trialAmrita Singh, Georgia Koutsoumpli, Stephanie van de Wall, et al.
Antiviral Research|July 31, 2012
Therapeutic vaccination against chronic hepatitis C virus infectionPeng Peng Ip, Hans W Nijman, Jan Wilschut, et al.
Plos Computational Biology|December 6, 2022
Modelling the spatial dynamics of oncolytic virotherapy in the presence of virus-resistant tumour cellsDarshak Kartikey Bhatt, Thijs Janzen, Toos Daemen, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 26, 2009
[Efficiency of human papillomavirus vaccination--estimates based on Dutch cost effectiveness analyses]Tjalke A Westra, Toos Daemen, Maarten J Postma, et al.
Vaccine|December 2, 2008
Augmentation of alphavirus vector-induced human papilloma virus-specific immune and anti-tumour responses by co-expression of interleukin-12Annelies Riezebos-Brilman, Joke Regts, Margaret Chen, et al.
Iscience|March 1, 2024
Oncolytic alphavirus replicons mediated recruitment and activation of T cellsDarshak K Bhatt, Saskia L Meuleman, Baukje Nynke Hoogeboom, et al.
Oncoimmunology|April 2, 2021
Re-polarization of immunosuppressive macrophages to tumor-cytotoxic macrophages by repurposed metabolic drugsCesar Oyarce, Ana Vizcaino-Castro, Shipeng Chen, et al.
Pageof 9

Showing results (11-20 of 82) with videos related to

Sort By:
Pageof 9
Vaccine|July 4, 2024
An in vitro CD8 T-cell priming assay enables epitope selection for hepatitis C virus vaccinesGeorgia Koutsoumpli, Neringa Stasiukonyte, Baukje Nynke Hoogeboom, et al.
Oncoimmunology|May 8, 2015
Myeloid derived suppressor cells-An overview of combat strategies to increase immunotherapy efficacyOana Draghiciu, Joyce Lubbers, Hans W Nijman, et al.
Scientific Reports|November 21, 2024
Effects of virus-induced immunogenic cues on oncolytic virotherapyDarshak K Bhatt, Thijs Janzen, Toos Daemen, et al.
Cancer Immunology, Immunotherapy : CII|November 23, 2018
An alphavirus-based therapeutic cancer vaccine: from design to clinical trialAmrita Singh, Georgia Koutsoumpli, Stephanie van de Wall, et al.
Antiviral Research|July 31, 2012
Therapeutic vaccination against chronic hepatitis C virus infectionPeng Peng Ip, Hans W Nijman, Jan Wilschut, et al.
Plos Computational Biology|December 6, 2022
Modelling the spatial dynamics of oncolytic virotherapy in the presence of virus-resistant tumour cellsDarshak Kartikey Bhatt, Thijs Janzen, Toos Daemen, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 26, 2009
[Efficiency of human papillomavirus vaccination--estimates based on Dutch cost effectiveness analyses]Tjalke A Westra, Toos Daemen, Maarten J Postma, et al.
Vaccine|December 2, 2008
Augmentation of alphavirus vector-induced human papilloma virus-specific immune and anti-tumour responses by co-expression of interleukin-12Annelies Riezebos-Brilman, Joke Regts, Margaret Chen, et al.
Iscience|March 1, 2024
Oncolytic alphavirus replicons mediated recruitment and activation of T cellsDarshak K Bhatt, Saskia L Meuleman, Baukje Nynke Hoogeboom, et al.
Oncoimmunology|April 2, 2021
Re-polarization of immunosuppressive macrophages to tumor-cytotoxic macrophages by repurposed metabolic drugsCesar Oyarce, Ana Vizcaino-Castro, Shipeng Chen, et al.
Pageof 9